Acute vascular effects of estrogen in postmenopausal women

Circulation

Volumn 90, Issue 2, 1994, Pages 786-791

  Gilligan, David M ^a   Badar, Diane M ^a   Panza, Julio A ^a   Quyyumi, Arshed A ^a   Cannon III, Richard O ^a,b  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

endothelium; endothelium derived factors; hormones; muscle, smooth; vasodilation

Indexed keywords

ACETYLCHOLINE; ALCOHOL; ENDOTHELIUM DERIVED RELAXING FACTOR; ESTRADIOL; ESTROGEN; NITROPRUSSIDE SODIUM;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; FEMALE; FOREARM BLOOD FLOW; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INTRAARTERIAL DRUG ADMINISTRATION; POSTMENOPAUSE; PRIORITY JOURNAL; VASCULAR RESISTANCE; VASODILATATION;

EID: 0027930853     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.90.2.786     Document Type: Article

References (33)

1. Barrett-Connor E, Bush TL. Estrogen and coronary heart disease. JAMA. 1991;265:1861-1867.
2. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med. 1991;20:47-63.
3. Stampfer MJ, Colditz GA, Willett WC, et al. Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the Nurses' Health Study. N Engl J Med. 1991;325:756-762.
4. Bush TL, Miller VT. Effects of pharmacologic agents used during menopause: impact on lipids and lipoproteins. In: Mishell DR, ed. Menopause: Physiology and Pharmacology. Chicago, Ill: Year Book Medical; 1987:187-208.
5. Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM. Effects of postmenopausal estrogen replacement on the concentration and metabolism of plasma lipoproteins. N Engl J Med. 1991;325:1196-1204.
6. Sarrel PM. Effects of ovarian steroids on the cardiovascular system. In: Ginsburg J, ed. Circulation in the Female. Park Ridge, NJ: Parthenon; 1989:117-140.
7. Jiang C, Sarrel PM, Lindsay DC, Poole-Wilson PA, Collins P. Endothelium-independent relaxation of rabbit coronary artery by 17β-oestradiol in vitro. Br J Pharmacol. 1991;104:1033-1037.
8. Bell C. Oestrogen-induced sensitization of the uterine artery of the guinea pig to acetylcholine. Br J Pharmacol. 1973;49:595-601.
9. Bell C, Coffey C. Factors influencing oestrogen-induced sensitization to acetylcholine of guinea-pig uterine artery. J Reprod Fertil. 1982;66:133-137.
10. Gisclard V, Miller VM, Vanhoutte PM. Effect of 17β-estradiol on endothelium-dependent responses in the rabbit. J Pharmacol Exp Ther. 1988;244:19-22.
11. Williams JK, Adams MR, Herrington DM, Clarkson TB. Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries. J Am Coll Cardiol. 1992;20: 452-457.
12. Colucci WS, Gimbrone MA, McLaughlin MK, Halpern W, Alexander RW. Increased vascular catecholamine sensitivity and α-adrenergic receptor affinity in female and estrogen-treated male rats. Circ Res. 1982;50:805-811.
13. Miller VM, Vanhoutte PM. 17β-Estradiol augments endothelium-dependent contractions to arachidonic acid in rabbit aorta. Am J Physiol. 1990;258:R1502-R1507.
14. Vane JR, Anggard EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med. 1990;323:27-36.
15. Dzau VJ, Gibbons GH, Cooke JP, Omoigui N. Vascular biology and medicine in the 1990s: scope, concepts, potentials, and perspectives. Circulation. 1993;87:705-719.
16. Ludmer PL, Selwyn AP, Shook TL, et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med. 1986;315:1046-1051.
17. Zeiher AM, Drexler H, Wollschläger H, Just H. Modulation of coronary vasomotor tone in humans: progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation. 1991;83:391-401.
18. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 1990;323:22-27.
19. Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation. 1993;87:1468-1474.
20. Creager MA, Gallagher SJ, Girerd XJ, Coleman SM, Dzau VJ, Cooke JP. L-Arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest. 1992;90: 1248-1253.
21. Casino PR, Kilcoyne CM, Quyyumi AA, Hoeg JM, Panza JA. Role of nitric oxide in the endothelium-dependent vasodilation of hypercholesterolemic patients. Circulation. 1993;88:2541-2547.
22. Calver A, Collier J, Vallance P. Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest. 1992;90:2548-2554.
23. McVeigh GE, Brennan GM, Johnston GD, et al. Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1992;35:771-776.
24. Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation. 1993;88:2510-2516.
25. Hokanson DE, Sumner DS, Strandness DE Jr. An electrically calibrated plethysmograph for direct measurement of limb blood flow. IEEE Trans Biomed Eng. 1975;22:25-29.
26. Abraham GE, Odell WD, Swerdloff RS, Hopper K. Simultaneous radioimmunoassay of plasma FSH, GH, progesterone, 17-hydroxyprogesterone, and estradiol-17β during the menstrual cycle. J Clin Endocrinol Metab. 1972;34:312-316.
27. Williams JK, Adams MR, Klopfenstein HS. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation. 1990; 81:1680-1687.
28. Furchgott RF, Zawadzki JV. The obligatory role of the endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;288:373-376.
29. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411-415.
30. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987;327:524-526.
31. Palmer RM, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 1988;333:664-666.
32. Sutherland RL, Watts CK, Clarke CL. Oestrogen actions. In: Cooke BA, King RJ, Van der Molen HJ, eds. Hormones and Their Actions. Amsterdam, the Netherlands: Elsevier; 1988:197-215.
33. Gilligan DM, Badar DA, Guetta V, Quyyumi AA, Panza JA, Cannon RO. Estradiol potentiation of endothelium-dependent vasodilation is dependent on nitric oxide production. J Am Coll Cardiol. 1994;23:378A. Abstract.